The Asia Pacific Reishi Mushroom Market would witness market growth of 8.5% CAGR during the forecast period (2022-2028).
They have a modest quantity of fat, protein, and complex carbs as macronutrients. Reishi is abundant in minerals like potassium, zinc, phosphorus, and manganese and also offers vital micronutrients. Additionally, about 400 bioactive substances, including triterpenoids, polysaccharides, nucleotides, steroids, sterols, fatty acids, and proteins/peptides, have been discovered by researchers.
Because wild reishi is so uncommon, it was formerly only given to monarchs and kings. However, this functional mushroom has been successfully grown by mycologists in robust and accessible forms on nutrient-rich substrates like organic oats. Reishi has a mildly bitter flavour but may be used into hot and cold beverages, as well as inventive recipes. It is offered in a variety of forms, including handy capsules and organically grown powders. It is suitable for consumption at any time of day.
Reishi mushrooms contain polysaccharide substances that are beneficial to the immune system in a variety of ways. Reishi affects cellular immunity by stimulating immune cells including macrophages and helper-T cells. Reishi has an impact on humoral immunity by stimulating the production of more immunoglobulin. By encouraging an enhanced immunological response, reishi helps the body's defence against infections including germs and viruses.
One of the world's biggest reishi mushroom growers is China. To suit the high demand on the domestic and international markets, the nation produces mushrooms on a big scale. Reishi is widely utilised in traditional Chinese medicine and is also referred to as the "Elixir of Life" and the "Mushroom of Immortality." As a result, there will likely be a significant rise in the demand for Reishi medicinal mushrooms in Asia-Pacific in the market under study. Reishi mushrooms are also widely utilised as medicine in several nations, including Korea and Japan.
The China market dominated the Asia Pacific Reishi Mushroom Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $574.8 million by 2028. The Japan market is poised to grow at a CAGR of 7.9% during (2022 - 2028). Additionally, The India market would showcase a CAGR of 9.2% during (2022 - 2028).
Based on End Use, the market is segmented into Pharmaceutical, Nutraceutical & Dietary Supplements, Food & Beverages and Cosmetics & Personal Care. Based on Form, the market is segmented into Powder and Liquid. Based on Nature, the market is segmented into Conventional and Organic. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Reishi Mushroom Market is Projected to reach USD 5.2 Billion by 2028, at a CAGR of 8.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Hokkaido Reishi Co. Ltd., Alphay International, Inc., Bio-Botanica, Inc., Bristol Botanicals Limited, Ron Teeguarden Enterprises, Inc., DXN Holdings Bhd., Xi'an Greena Biotech Co., Ltd., Nammex, JHS Natural Products, Inc. (Mushroom Science)
By End Use
By Form
By Nature
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.